| Dr Mark Wiiliam Rose, MD | |
|
67 Union St, Suite 304, Natick, MA 01760-7700 | |
| (508) 653-7311 | |
| (508) 653-0549 |
| Full Name | Dr Mark Wiiliam Rose |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 39 Years |
| Location | 67 Union St, Natick, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790871804 | NPI | - | NPPES |
| Y70826 | Other | MA | BLUE CROSS BLUE SHIELD |
| 33122 | Other | MA | HARVARD PILGRIM HEALTH CA |
| 0361739 | Medicaid | MA | |
| 001800 | Other | MA | TUFTS MEDICARE PREFERRED |
| 001800 | Other | MA | TUFTS HEALTH PLAN |
| 3818 | Other | MA | FALLON |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 1800 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metrowest Medical Center | Framingham, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedics New England Inc | 6800976770 | 23 |
News Archive
The poisoning of Mr Alexander Litvinenko with radioactive polonium-210 in London in November 2006 had political consequences internationally and presented the Health Protection Agency with some unique public health challenges. Professor Pat Troop, Chief Executive of the Agency, will open a session on the response to the incident at the HPA conference at Warwick University today and give a keynote address on how it was handled.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health.
In 1980, men and women who were diagnosed with the human immunodeficiency virus (HIV) had little to no hope of living long, full lives. Thanks to advances in science and medicine, this is no longer the case. HIV patients now live a near-normal lifespan. However, as patients live longer, new medical issues arise.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 5 days ago
| Provider Name | Orthopedics New England Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1497835839 PECOS PAC ID: 6800976770 Enrollment ID: O20100719000323 |
News Archive
The poisoning of Mr Alexander Litvinenko with radioactive polonium-210 in London in November 2006 had political consequences internationally and presented the Health Protection Agency with some unique public health challenges. Professor Pat Troop, Chief Executive of the Agency, will open a session on the response to the incident at the HPA conference at Warwick University today and give a keynote address on how it was handled.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health.
In 1980, men and women who were diagnosed with the human immunodeficiency virus (HIV) had little to no hope of living long, full lives. Thanks to advances in science and medicine, this is no longer the case. HIV patients now live a near-normal lifespan. However, as patients live longer, new medical issues arise.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Wiiliam Rose, MD 313 Speen St, Natick, MA 01760-1538 Ph: (508) 653-7311 | Dr Mark Wiiliam Rose, MD 67 Union St, Suite 304, Natick, MA 01760-7700 Ph: (508) 653-7311 |
News Archive
The poisoning of Mr Alexander Litvinenko with radioactive polonium-210 in London in November 2006 had political consequences internationally and presented the Health Protection Agency with some unique public health challenges. Professor Pat Troop, Chief Executive of the Agency, will open a session on the response to the incident at the HPA conference at Warwick University today and give a keynote address on how it was handled.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it has entered into a definitive purchase agreement under which Quest will acquire Summit Health.
In 1980, men and women who were diagnosed with the human immunodeficiency virus (HIV) had little to no hope of living long, full lives. Thanks to advances in science and medicine, this is no longer the case. HIV patients now live a near-normal lifespan. However, as patients live longer, new medical issues arise.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
Rockland Immunochemicals, Inc. announces the availability of a new collection of human melanoma cell lines that have been developed and characterized over several decades in the laboratory of Meenhard Herlyn, D.V.M., D.Sc., Caspar Wistar Professor in Melanoma Research, Director of the Melanoma Research Center, and professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute in Philadelphia.
› Verified 5 days ago
Dr. Michael Anthony Robinson, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 67 Union St Ste 310, Natick, MA 01760 Phone: 617-277-2662 Fax: 617-734-9733 | |
Sports Podiatry Resource Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 67 Union St Ste 310, Natick, MA 01760 Phone: 617-277-2662 Fax: 617-734-9733 | |
Dr. Mark Rose Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 67 Union St, Ste 304, Natick, MA 01760 Phone: 617-361-9776 Fax: 617-361-1254 | |
Sports Podiatry Resource, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 67 Union St, Suite 310, Natick, MA 01760 Phone: 508-653-8888 Fax: 617-734-9733 | |
Philip F. Lukoff Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 192 Worcester Rd, Natick, MA 01760 Phone: 508-650-3668 Fax: 508-650-1159 | |
Ryan T Cooney, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 67 Union St, Suite 304, Natick, MA 01760 Phone: 508-653-7311 Fax: 508-653-0549 |